Disparities in lung health remain a significant public health concern, disproportionately affecting individuals from low-income communities, minority populations, and regions with limited access to healthcare resources. Reducing lung health disparities involves addressing the social, economic, and environmental factors that contribute to unequal respiratory outcomes. These include exposure to air pollution, tobacco smoke, occupational hazards, inadequate housing, and limited access to preventive and specialized healthcare services. Strategies to reduce lung health disparities focus on community engagement, public health education, and the implementation of equitable healthcare programs that ensure timely screening, diagnosis, and management of respiratory conditions. Tailored interventions, such as mobile clinics, telehealth services, and culturally sensitive educational materials, can bridge gaps in care and empower individuals to take an active role in managing their respiratory health. Collaboration among healthcare providers, policymakers, and community organizations is critical to designing and sustaining programs that target high-risk populations while promoting health equity. Evidence-based initiatives, including smoking cessation campaigns, vaccination drives, and environmental risk mitigation, have demonstrated measurable improvements in lung function and reduced incidence of chronic respiratory diseases in underserved populations. Reducing lung health disparities also requires ongoing evaluation and research to identify emerging challenges and assess the effectiveness of interventions. By prioritizing equity and accessibility in respiratory care, healthcare systems can ensure that all individuals, regardless of socioeconomic or geographic factors, have the opportunity to achieve optimal lung health and improved quality of life.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation